Kennedy Capital Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-253,954
| Closed | -$4.23M | – | 806 |
|
|
2017
Q3 | $4.23M | Buy |
+253,954
| New | +$4.13M | 0.08% | 465 |
|
|
2017
Q2 | – | Sell |
-63,400
| Closed | -$1.27M | – | 790 |
|
|
2017
Q1 | $1.27M | Buy |
+63,400
| New | +$1.48M | 0.02% | 647 |
|
|
2016
Q2 | – | Sell |
-99,614
| Closed | -$1.69M | – | 775 |
|
|
2016
Q1 | $1.69M | Buy |
99,614
+63,675
| +177% | +$1.31M | 0.03% | 610 |
|
|
2015
Q4 | $798K | Sell |
35,939
-682,715
| -95% | -$14.2M | 0.02% | 678 |
|
|
2015
Q3 | $12.2M | Buy |
718,654
+230,652
| +47% | +$3.59M | 0.25% | 101 |
|
|
2015
Q2 | $6.71M | Sell |
488,002
-3,347
| -0.7% | -$44.5K | 0.12% | 307 |
|
|
2015
Q1 | $6.73M | Buy |
491,349
+50,050
| +11% | +$578K | 0.12% | 317 |
|
|
2014
Q4 | $4.67M | Buy |
441,299
+107,453
| +32% | +$1.27M | 0.09% | 416 |
|
|
2014
Q3 | $4.17M | Sell |
333,846
-283,660
| -46% | -$3.96M | 0.08% | 414 |
|
|
2014
Q2 | $8.45M | Buy |
617,506
+83,360
| +16% | +$1.09M | 0.16% | 242 |
|
|
2014
Q1 | $6.45M | Buy |
534,146
+56,166
| +12% | +$643K | 0.12% | 317 |
|
|
2013
Q4 | $5.87M | Buy |
477,980
+144,015
| +43% | +$1.69M | 0.11% | 349 |
|
|
2013
Q3 | $3.4M | Sell |
333,965
-1,857
| -0.6% | -$17.4K | 0.07% | 452 |
|
|
2013
Q2 | $3.02M | Buy |
+335,822
| New | +$3.38M | 0.06% | 461 |
|
Kennedy Capital Management's OME Position: Q4 2017 in Review
Kennedy Capital Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 253,954 shares — an estimated $4.23M sold.
Kennedy Capital Management first reported a position in OME in Q2 2013 and held it in 14 quarters. The position peaked at $12.2M in Q3 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Kennedy Capital Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Kennedy Capital Management sold 253,954 Omega Protein shares in Q4 2017, an estimated $4.23M.
- Kennedy Capital Management first reported a position in Omega Protein in Q2 2013 and held it in 14 quarters.
- Kennedy Capital Management's Omega Protein position peaked at $12.2M in Q3 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Kennedy Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.